Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

Diabetic Medicine : a Journal of the British Diabetic Association
S SchmaussR Landgraf

Abstract

The short-acting insulin analogue lispro ([LYS(B28), PRO(B29)] is absorbed from the subcutis more rapidly than soluble insulin (S). To compare the clinical effectiveness of lispro vs S, 11 Type 1 patients using continuous subcutaneous insulin infusion (CSII) therapy (6 F, 5 M, age 30 +/- 2.5 years, diabetes duration 14 +/- 1.0 years, BMI 24.0 +/- 0.8 kg m(-2), HbA1c 6.5 +/- 0.2%) were studied in an open, randomized, crossover study for 6 months (3 months lispro and 3 months S or vice versa). During lispro treatment mean fasting and 2 h postprandial blood glucose were lower compared to the S phase (fasting 6.5 +/- 0.4 vs 7.5 +/- 0.4 mmol l(-1) (NS), postprandial 6.8 +/- 0.3 vs 8.3 +/- 0.3 mmol l(-1), p = 0.03). In patients treated first with lispro HbA1c levels improved from 6.3 +/- 0.2% to 5.7 +/- 0.3%; On reversion to S HbA1c increased to 6.2 +/- 0.2%. In the group treated first with S, HbA1c fell (6.7 +/- 0.4% vs 6.5 +/- 0.3%) and then improved further to 6.3 +/- 0.3% with lispro. None of these changes were significant. There was no significant difference with respect to hypoglycaemic or other adverse events. It can be concluded that lispro in CSII therapy is safe and may improve postprandial glucose excursions.

Citations

Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sumeet R SinghHeather Bennett
Feb 28, 2001·Diabetes, Obesity & Metabolism·S K GargH P Chase
Jun 21, 2005·Journal of Advanced Nursing·Unn-Britt JohanssonRegina Wredling
Aug 28, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·C PratoomsootW J Valentine
Sep 27, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·J ColquittN Waugh
Apr 7, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kirsten NørgaardPonnusamy Saravanan
Aug 10, 2000·Drugs·J M Chehade, A D Mooradian
Apr 21, 2006·The Cochrane Database of Systematic Reviews·A SiebenhoferT R Pieber
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Justen W Rudolph, Irl B Hirsch
Apr 29, 2008·Arquivos brasileiros de endocrinologia e metabologia·Walter José Minicucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.